We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Simple Blood Test Identifies Organs Likely to Fail First

By LabMedica International staff writers
Posted on 07 Dec 2023

Similar to a typical car or house or society, the speed at which parts of the human body fall apart differs from part to part. More...

In a groundbreaking study, researchers have developed a novel method to analyze organ aging by examining specific proteins or sets of proteins in the blood. This approach can predict an individual's risk for various diseases.

Investigators at Stanford Medicine (Stanford, CA, USA) conducted a study involving 5,678 participants that revealed organ age at varying rates. The research found that when an organ is significantly older than what is typical for a person's chronological age, that individual faces an increased risk for diseases related to that organ, as well as a higher mortality risk. The study found that approximately 20% of healthy adults over 50 have at least one organ aging much faster than normal. This finding suggests that a simple blood test could identify which organs in a person are aging rapidly, potentially allowing for early intervention before symptoms appear. Previous studies have generated single numbers to represent biological age, contrasting with chronological age. However, this new research assigns specific aging numbers to 11 key organs and systems: the heart, fat, lung, immune system, kidney, liver, muscle, pancreas, brain, vasculature, and intestine.

The researchers utilized available technologies and a unique algorithm to measure thousands of blood proteins, identifying nearly 1,000 proteins linked to specific organs. Abnormal protein levels were associated with accelerated aging of corresponding organs, increasing susceptibility to disease and death. They calculated an "age gap" for each organ, representing the difference between its actual and algorithm-predicted age. The study found significant associations between these age gaps and future mortality risk over 15 years, except for the intestine. An accelerated-aging organ, defined as having a biological age one standard deviation higher than the average for that organ in people of the same chronological age, was associated with a 15% to 50% increased mortality risk over the following 15 years.

The study also found that accelerated heart aging significantly increased the risk of heart failure, while older brains correlated with a higher likelihood of cognitive decline. Accelerated aging in the brain or vasculature was a strong predictor of Alzheimer’s disease progression. Additionally, there were clear connections between extremely aged kidneys and conditions like hypertension and diabetes, as well as between aged hearts and atrial fibrillation or heart attacks. The identification of organ-specific proteins that indicate excessive aging could also lead to new therapeutic targets, paving the way for drug development and more personalized medical interventions.

“We can estimate the biological age of an organ in an apparently healthy person,” said the study’s senior author, Tony Wyss-Coray, PhD, a professor of neurology and the D. H. Chen Professor II. “That, in turn, predicts a person’s risk for disease related to that organ.”

Related Links:
Stanford Medicine


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Automatic CLIA Analyzer
Shine i6000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Lead author Professor Chamindie Punyadeera. (Image Credit: Griffith University)

Breath Analysis Shows Promise for Distinguishing Cancerous from Benign Lung Nodules

Lung nodules are frequently detected during imaging, but distinguishing malignant from benign findings can require invasive procedures. Some patients undergo biopsies, bronchoscopy, or surgery before learning... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Each PhAST instrument supports random-access processing of up to four samples simultaneously, delivering a throughput of up to 12 samples per eight-hour shift. (Photo courtesy of PhAST)

FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures

Bloodstream infections require prompt treatment, but antimicrobial susceptibility results often lag behind a positive blood culture. Conventional testing can take another 24 to 48 hours after a culture... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.